ENTX Entera Bio Ltd. Ordinary Shares BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

ENTX Stock Analysis: Buy, Sell, or Hold?

$3.11
-0.11 (-3.42%) â–ŧ
5d: -0.96% 30d: +12.27% 90d: +7.24%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
47/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$2.67 – $3.18
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-7.1x
Next 12M consensus est.
Wall Street Target
$9.75
+213.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.90 / $3.49
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: ENTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When ENTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ENTX is currently trading at $3.11, which is considered slightly high relative to its 30-day fair value range of $2.67 to $3.18.

Technical Outlook: Technically, ENTX is in a uptrend. Immediate support is located at $2.90, while resistance sits at $3.49. Short-term momentum is weak, with the stock down 3.4% recently.

Market Sentiment: ENTX scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.75 (+213.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $2.67 - $3.18
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 50.0%

Trading Range & Key Levels

30-Day Trading Range $2.67 - $3.18
Current vs Trading Range SLIGHTLY HIGH
Expected Move (7 Days) Âą$0.50 (16.0%)
Support Level $2.90
Resistance Level $3.49
Current Trend Uptrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (29/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.4%)
  • BULLISH: Trading 213.5% below Wall St target ($9.75)
  • WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -7.10
Wall Street Target $9.75 (+213.5%)
Revenue Growth (YoY) -100.0%
Share ENTX Analysis

Share this live ENTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ENTX)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 18, 2026
Daily AI digest
AI Retail Discussion Summary: One bullish StockTwits message predicts a $3,12 increase for $ENTX stocks.
Key Retail Themes: Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:44 PM ET
Data refreshes hourly during market hours. Next update: 6:44 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ENTX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 49 HOLD
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 33 SELL
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 39 SELL
DNTH
Dianthus Therapeutics Inâ€Ļ
STRONG BUY
18 analysts
$139 35 SELL
ARDX
Ardelyx Inc
STRONG BUY
11 analysts
$13 69 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ENTX Research Pages
ENTX Technical Chart ENTX Price Prediction ENTX Intrinsic Value DCF ENTX Earnings Date ENTX Investment Advisor ENTX Fair Price Analyzer ENTX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals